Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 5,090.00
-300.00 (-5.57%)
At close: Jan 30, 2026
Protia Market Cap
Protia has a market cap or net worth of 65.55 billion as of January 30, 2026. Its market cap has increased by 82.44% in one year.
Market Cap
65.55B
Enterprise Value
51.61B
Revenue
13.52B
Ranking
n/a
PE Ratio
17.26
Stock Price
5,090.00
Market Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 65.55B, a decrease of -16.41%. That is a compound annual growth rate of -2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 69.41B | -13.62% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 474.83B |
| Dx & Vx | 320.88B |
| Cytogen | 190.32B |
| GENINUS | 136.41B |
| HLB PANAGENE Co., LTD. | 85.30B |
| Green Cross Medical Science | 84.68B |
| Seoulin Bioscience | 59.58B |
| GeneMatrix | 49.45B |